文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

直肠癌患者行直肠系膜全切除(TME)与局部切除后补救性 TME 的短期疗效比较:基于人群的倾向性匹配研究

Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study.

机构信息

Department of Surgery, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands.

出版信息

BJS Open. 2024 Sep 3;8(5). doi: 10.1093/bjsopen/zrae103.


DOI:10.1093/bjsopen/zrae103
PMID:39235090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375580/
Abstract

BACKGROUND: Colorectal cancer screening programmes have led to a shift towards early-stage colorectal cancer, which, in selected cases, can be treated using local excision. However, local excision followed by completion total mesorectal excision (two-stage approach) may be associated with less favourable outcomes than primary total mesorectal excision (one-stage approach). The aim of this population study was to determine the distribution of treatment strategies for early rectal cancer in the Netherlands and to compare the short-term outcomes of primary total mesorectal excision with those of local excision followed by completion total mesorectal excision. METHODS: Short-term data for patients with cT1-2 N0xM0 rectal cancer who underwent local excision only, primary total mesorectal excision, or local excision followed by completion total mesorectal excision between 2012 and 2020 in the Netherlands were collected from the Dutch Colorectal Audit. Patients were categorized according to treatment groups and logistic regressions were performed after multiple imputation and propensity score matching. The primary outcome was the end-ostomy rate. RESULTS: From 2015 to 2020, the proportion for the two-stage approach increased from 22.3% to 43.9%. After matching, 1062 patients were included. The end-ostomy rate was 16.8% for the primary total mesorectal excision group versus 29.6% for the local excision followed by completion total mesorectal excision group (P < 0.001). The primary total mesorectal excision group had a higher re-intervention rate than the local excision followed by completion total mesorectal excision group (16.7% versus 11.8%; P = 0.048). No differences were observed with regard to complications, conversion, diverting ostomies, radical resections, readmissions, and death. CONCLUSION: This study shows that, over time, cT1-2 rectal cancer has increasingly been treated using the two-stage approach. However, local excision followed by completion total mesorectal excision seems to be associated with an elevated end-ostomy rate. It is important that clinicians and patients are aware of this risk during shared decision-making.

摘要

背景:结直肠癌筛查项目促使结直肠癌向早期阶段转移,在某些情况下,可以采用局部切除的方式进行治疗。然而,局部切除后行全直肠系膜切除术(两阶段方法)可能与原发性全直肠系膜切除术(一阶段方法)相比,结局较差。本项人群研究旨在确定荷兰早期直肠癌治疗策略的分布,并比较原发性全直肠系膜切除术与局部切除后行全直肠系膜切除术的短期结局。

方法:从荷兰结直肠审计中收集了 2012 年至 2020 年间荷兰接受单纯局部切除、原发性全直肠系膜切除术或局部切除后行全直肠系膜切除术的 cT1-2 N0xM0 直肠癌患者的短期数据。患者根据治疗组进行分类,并在多次插补和倾向评分匹配后进行逻辑回归。主要结局是造口率。

结果:从 2015 年至 2020 年,两阶段方法的比例从 22.3%增加到 43.9%。匹配后,纳入 1062 例患者。原发性全直肠系膜切除术组的造口率为 16.8%,局部切除后行全直肠系膜切除术组为 29.6%(P < 0.001)。原发性全直肠系膜切除术组的再次干预率高于局部切除后行全直肠系膜切除术组(16.7%对 11.8%;P = 0.048)。两组之间的并发症、转化率、转流造口、根治性切除术、再入院和死亡率均无差异。

结论:本研究表明,随着时间的推移,cT1-2 直肠癌症越来越多地采用两阶段方法进行治疗。然而,局部切除后行全直肠系膜切除术似乎与较高的造口率有关。在共同决策过程中,临床医生和患者都需要意识到这种风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/c75d42d49760/zrae103f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/af5089a1f68a/zrae103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/53a62c9c3610/zrae103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/f8ff985182b5/zrae103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/07e730805e7c/zrae103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/c75d42d49760/zrae103f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/af5089a1f68a/zrae103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/53a62c9c3610/zrae103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/f8ff985182b5/zrae103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/07e730805e7c/zrae103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb3/11375580/c75d42d49760/zrae103f5.jpg

相似文献

[1]
Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study.

BJS Open. 2024-9-3

[2]
Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.

Dis Colon Rectum. 2020-11

[3]
Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis.

Surg Endosc. 2018-7-2

[4]
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.

Lancet Gastroenterol Hepatol. 2021-2

[5]
Completion total mesorectal excision following transanal endoscopic microsurgery does not compromise outcomes in patients with rectal cancer.

Surg Endosc. 2022-2

[6]
[Comparative study of functional prognosis of transanal total mesorectal excision and conventional total mesorectal excision based on propensity score matching].

Zhonghua Wai Ke Za Zhi. 2020-8-1

[7]
Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score Matched, Population-Based Study in Catalonia, Spain.

Dis Colon Rectum. 2022-2-1

[8]
Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid/low rectal cancer: European multicentre, propensity score-matched study.

BJS Open. 2024-5-8

[9]
Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.

Surg Endosc. 2018-10-22

[10]
Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.

J Visc Surg. 2018-12

引用本文的文献

[1]
Mid- and long-term functional outcomes of advancement flap for cryptoglandular perianal fistulas.

Tech Coloproctol. 2025-5-9

[2]
Stoma Rate and Oncological Outcomes of Primary TaTME vs Completion TaTME in Patients With Early-Stage Rectal Cancer.

Dis Colon Rectum. 2025-8-1

本文引用的文献

[1]
Completion Total Mesorectal Excision: A Case-Matched Comparison With Primary Resection.

Ann Surg Open. 2023-8-23

[2]
Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression.

Surg Endosc. 2022-12

[3]
Completion surgery vs. primary TME for early rectal cancer: a national study.

Int J Colorectal Dis. 2022-2

[4]
Multidisciplinary management of early rectal cancer - The role of surgical local excision in current and future clinical practice.

Surg Oncol. 2022-3

[5]
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.

Lancet Oncol. 2021-7

[6]
Completion total mesorectal excision following transanal endoscopic microsurgery does not compromise outcomes in patients with rectal cancer.

Surg Endosc. 2022-2

[7]
Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?

Dis Colon Rectum. 2021-2-1

[8]
Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.

Br J Surg. 2020-12

[9]
Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?

Eur J Surg Oncol. 2020-9

[10]
MRI cT1-2 rectal cancer staging accuracy: a population-based study.

Br J Surg. 2020-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索